Statera Biopharma Inc. Gains 100%
Fri, Sep 27, 2024 at 07:34 PM
Statera Biopharma Inc. (STAB:NASDAQ) shot up at $0, a gain of 100%. On Fri, Sep 27, 2024, STAB:NASDAQ touched a New 2-Week High of $0. From Fri, Sep 13, 2024, the stock recorded 0.00% Up Days and 0.00% Green Days
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- Scopus BioPharma Inc. (SCPS:NASDAQ), 200%
- Statera Biopharma Inc. (STAB:NASDAQ), 100%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Uxin Limited (UXIN:NASDAQ), 83.75%
- Vinco Ventures Inc. (BBIG:NASDAQ), 80%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Onconetix Inc Com (ONCO:NASDAQ), 75.81%
- 9F Inc. (JFU:NASDAQ), 74.24%
- Nano Labs Ltd (NA:NASDAQ), 74.17%
- CN Energy Group Inc. (CNEY:NASDAQ), 65.55%